Product NDC: | 42023-125 |
Proprietary Name: | Dantrium |
Non Proprietary Name: | dantrolene sodium |
Active Ingredient(s): | 50 mg/1 & nbsp; dantrolene sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42023-125 |
Labeler Name: | JHP Pharmaceuticals LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017443 |
Marketing Category: | NDA |
Start Marketing Date: | 20080801 |
Package NDC: | 42023-125-01 |
Package Description: | 100 CAPSULE in 1 BOTTLE (42023-125-01) |
NDC Code | 42023-125-01 |
Proprietary Name | Dantrium |
Package Description | 100 CAPSULE in 1 BOTTLE (42023-125-01) |
Product NDC | 42023-125 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | dantrolene sodium |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20080801 |
Marketing Category Name | NDA |
Labeler Name | JHP Pharmaceuticals LLC |
Substance Name | DANTROLENE SODIUM |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC] |